603990 Suzhou MedicalSystem Techology
- 12.98
- +1.18+10.00%
Suzhou MedicalSystem Techology News
Suzhou MedicalSystem Technology (603990.SH): As of now, Suzhou Youmai has been established, and the project currently has a small investment.
On January 10, Glonghui reported that Suzhou MedicalSystem Technology (603990.SH) announced a stock trade risk warning. The company noted that recently the Robot Concept has received a high level of market attention. On September 12, 2024, the company established a joint venture called Suzhou Youmai Robot Co., Ltd. with Shenzhen Youbixuan Technology Co., Ltd. (hereinafter referred to as "Youbixuan"), with a registered capital of 20 million yuan, and the company's shareholding ratio is 51%. On December 30, 2024, the company held its fifth extraordinary Shareholder meeting of 2024, reviewing and approving the proposal on the use of surplus funds from certain fundraising projects for new projects.
Musk: The goal this year is to manufacture thousands of Optimus humanoid robots, aiming for a tenfold increase each year over the next two years.
Musk stated that if everything goes smoothly, the production of humanoid robots will increase tenfold by 2026, with the goal of producing between 0.05 million to 0.1 million humanoid robots next year, and then increasing it tenfold again the following year.
Suzhou MedicalSystem Technology (603990.SH): Two Shareholders plan to collectively reduce their Shareholding by no more than 1.7089 million shares.
On December 20, Gelonghui reported that Suzhou MedicalSystem Technology (603990.SH) announced that Mr. Wang Jianhua plans to reduce his shareholding in the company by no more than 947,500 shares, which does not exceed 25% of his total shares held, and does not exceed 0.3094% of the company's total share capital, within three months after the announcement of this plan. If there are changes in shares such as stock dividends or capitalization during the shareholding reduction plan period, the number of shares to be reduced will be adjusted accordingly. Mr. Fu Hong plans to reduce his shareholding via block trading and centralized bidding within three months after the announcement of this plan.
What Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) 27% Share Price Gain Is Not Telling You
Suzhou MedicalSystem Technology (603990.SH): Plans to terminate the remaining raised funds of 43.5479 million yuan from the "High-efficiency CECEP Solar Energy Battery Intelligent Manufacturing Project" for the new project "Innovation Product R&D Center P
On December 13th, GeLonghui reported that Suzhou MedicalSystem Technology (603990.SH) announced that on December 13, 2024, the company held the twenty-eighth meeting of the fourth Board of Directors, which passed the proposal "To use the surplus funds from some fundraising projects for new projects" with 5 votes in favor, 0 votes against, and 0 abstentions. According to the company's future strategic development plan, in order to enhance the company's Operation capabilities, seize market development opportunities brought about by new business formats and new technologies, and improve the company's market competitiveness, the company intends to terminate the remaining raised funds of 43.5479 million yuan from the "Efficient CECEP Solar Energy Battery Intelligent Manufacturing Project" for the new project "Chuang.
Would Suzhou MedicalSystem Technology (SHSE:603990) Be Better Off With Less Debt?
Suzhou medicalsystem technology (603990.SH): A special division has been established to continue advancing the research and development of drone low-altitude rescue.
Gelonghui November 14th | Suzhou medicalsystem techology (603990.SH) stated on the investor interaction platform that the company has established a special business unit to continue the research and development work of low-altitude drone rescue, continuously connecting with emergency centers and following up on demands, constantly improving and testing the products.
Suzhou Medicalsystem Technology (603990.SH): will deeply explore in AI Asia Vets services and medical care and health field, to create a new growth curve.
On November 14, Glonghui reported that Suzhou Medicalsystem Technology (603990.SH) announced on the investor interaction platform that it established Suzhou Youmai Robot Co., Ltd. on September 12, 2024. The main operational scope includes the research and development and sales of asia vets. The company will deeply explore AI smart services and the medical health care field to create a new growth curve.
Maddie Technology: Maddie Technology Third Quarter 2024 Report
Maddie Technology 2024 Third Quarter Report
Suzhou medicalsystem technology (603990.SH): Intends to sell 100% equity of two subsidiaries.
GLEE10 reported on October 30th that Suzhou Medicalsystem Technology (603990.SH) announced that the company plans to sell 100% equity of Mianyang Xinhaoyuan New Energy Technology Co., Ltd. held by Mianyang Anjian Investment Co., Ltd. in cash and to sell 100% equity of Mainsource Electrical Technology (Suzhou) Co., Ltd. held by Suzhou Xinnuo New Energy Technology Co., Ltd.
It is expected that relevant national authorities will establish a low-altitude economic regulatory bureau.
①The establishment decision has been approved, and the new bureau is currently in preparation; ② The low-altitude economy set up a dedicated bureau, which can better coordinate resources at all levels to promote industrial development.
Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Share Price Boosted 41% But Its Business Prospects Need A Lift Too
Increasing Losses Over Year Doesn't Faze Suzhou MedicalSystem Technology (SHSE:603990) Investors as Stock Rallies 18% This Past Week
Suzhou MedicalSystem Technology (603990.SH): gradually forming a comprehensive low-altitude rescue solution based on drone and eVTOL technology.
On August 16th, Gelunhui reported that Suzhou MedicalSystem Technology Co., Ltd. stated on its investor interactive platform that the company has been deeply cultivating the medical sector for nearly 20 years, and is a leader in the industry in the collaborative treatment of critical and severe diseases in hospitals and the field of assisted reproduction. By combining Huawei Cloud's leading technologies in cloud computing & big models, the company promotes the high-quality development of smart medical care and promotes the landing of AI applications in emergency medical care. Recently, the company has vigorously promoted the industry integration of medical informatization business and cooperated with industry companies in the fields of low-altitude economy, health and wellness robots and other fields. In terms of low-altitude economic emergency rescue, it has reached cooperation with Xi'an Jiaotong University Taicang Zhihui Port.
Suzhou Medicalsystem Technology (603990.SH): Vice President Wu Di accumulated a shareholding of 0.052 million shares of the company's stock.
On August 12th, Gelunhui reported that Suzhou Medicalsystem Technology (603990.SH) has received a notification letter from its Vice President Mr. Wu Di regarding the completion of the shareholding plan. Wu Di has accumulated 52,000 shares through centralized bidding from February 1st to August 12th, 2024, accounting for 0.0170% of the company's total equity, with a total accumulated investment of 503,480 yuan. Among them, from February 1st to July 31st, 2024, he accumulated 49,000 shares, with a total investment of 479.
Suzhou Mediston Medical Technology Co., Ltd. 2024 Interim Report
Summary of the semi-annual report of Suzhou Midesun Medical Technology Co., Ltd. in 2024.
Suzhou Medicalsystem Technology (603990.SH) plans to sell 100% equity of Xinhao New Energy Fund.
On August 9, Gelunhui reported that Suzhou MedicalSystem Technology Co., Ltd. (603990.SH) is planning a major asset restructuring, intending to sell 100% equity of Mianyang Xinhao New Energy Technology Co., Ltd. (hereinafter referred to as 'Xinhao New Energy') held by the company (hereinafter referred to as the 'target assets'). The target assets of this transaction are 100% equity of Xinhao New Energy, a wholly-owned subsidiary of the company. After preliminary studies and calculations, it is expected that this transaction will constitute a major asset restructuring as stipulated in the 'Management Measures for Major Asset Restructuring of Listed Companies'. The transaction is still in the planning stage, and the counterparty and transaction price have not been determined, and whether it constitutes a related party transaction is yet to be determined.
Suzhou Medicalsystem Techology (603990.SH): Repurchased 1.1764% of the shares, and the company completed the repurchase.
On August 2nd, 2024, Suzhou Medicalsystem Technology (603990.SH) announced that it had completed its buyback program, purchasing a total of 3.603 million shares, accounting for 1.1764% of the company's total share capital. The highest purchase price was 8.86 yuan per share, the lowest purchase price was 7.76 yuan per share, and the average purchase price was 8.32 yuan per share, with a total funds used of 29.9662 million yuan.
No Data
